Claudia H. T. Tam,Cadmon K. P. Lim,Andrea O. Y. Luk,Alex C. W. Ng,Heung-man Lee,Guozhi Jiang,Eric S. H. Lau,Baoqi Fan,Raymond Wan,Alice P. S. Kong,Wing-hung Tam,Risa Ozaki,Elaine Y. K. Chow,Ka-fai Lee,Shing-chung Siu,Grace Hui,Chiu-chi Tsang,Kam-piu Lau,Jenny Y. Y. Leung,Man-wo Tsang,Grace Kam,Ip-tim Lau,June K. Y. Li,Vincent T. F. Yeung,Emmy Lau,Stanley Lo,Samuel Fung,Yuk-lun Cheng,Chun-chung Chow,Miao Hu,Weichuan Yu,Stephen K. W. Tsui,Yu Huang,Huiyao Lan,Cheuk-chun Szeto,Nelson L. S. Tang,Maggie C. Y. Ng,Wing-yee So,Brian Tomlinson,Juliana C. N. Chan,Ronald C. W. Ma,,

Abstract:Abstract Background The clinical utility of personal genomic information in identifying individuals at increased risks for dyslipidemia and cardiovascular diseases remains unclear. Methods We used data from Biobank Japan ( n = 70,657–128,305) and developed novel East Asian-specific genome-wide polygenic risk scores (PRSs) for four lipid traits. We validated ( n = 4271) and subsequently tested associations of these scores with 3-year lipid changes in adolescents ( n = 620), carotid intima-media thickness (cIMT) in adult women ( n = 781), dyslipidemia ( n = 7723), and coronary heart disease (CHD) ( n = 2374 cases and 6246 controls) in type 2 diabetes (T2D) patients. Results Our PRSs aggregating 84–549 genetic variants (0.251 < correlation coefficients ( r ) < 0.272) had comparably stronger association with lipid variations than the typical PRSs derived based on the genome-wide significant variants (0.089 < r < 0.240). Our PRSs were robustly associated with their corresponding lipid levels (7.5 × 10 − 103 < P < 1.3 × 10 − 75 ) and 3-year lipid changes (1.4 × 10 − 6 < P < 0.0130) which started to emerge in childhood and adolescence. With the adjustments for principal components (PCs), sex, age, and body mass index, there was an elevation of 5.3% in TC ( β ± SE = 0.052 ± 0.002), 11.7% in TG ( β ± SE = 0.111 ± 0.006), 5.8% in HDL-C ( β ± SE = 0.057 ± 0.003), and 8.4% in LDL-C ( β ± SE = 0.081 ± 0.004) per one standard deviation increase in the corresponding PRS. However, their predictive power was attenuated in T2D patients (0.183 < r < 0.231). When we included each PRS (for TC, TG, and LDL-C) in addition to the clinical factors and PCs, the AUC for dyslipidemia was significantly increased by 0.032–0.057 in the general population (7.5 × 10 − 3 < P < 0.0400) and 0.029–0.069 in T2D patients (2.1 × 10 − 10 < P < 0.0428). Moreover, the quintile of TC-related PRS was moderately associated with cIMT in adult women ( β ± SE = 0.011 ± 0.005, P trend = 0.0182). Independent of conventional risk factors, the quintile of PRSs for TC [OR (95% CI) = 1.07 (1.03–1.11)], TG [OR (95% CI) = 1.05 (1.01–1.09)], and LDL-C [OR (95% CI) = 1.05 (1.01–1.09)] were significantly associated with increased risk of CHD in T2D patients (4.8 × 10 − 4 < P < 0.0197). Further adjustment for baseline lipid drug use notably attenuated the CHD association. Conclusions The PRSs derived and validated here highlight the potential for early genomic screening and personalized risk assessment for cardiovascular disease.

Development and Validation of a Polygenic Risk Score for Stroke in the Chinese Population

A Comprehensive Contribution of Genetic Variations of the Insulin-Like Growth Factor 1 Signalling Pathway to Stroke Susceptibility

Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese

A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease

Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: Evidence from the China Kadoorie Biobank

Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease in a Chinese Cohort

Integrating transcriptomic and polygenic risk scores to enhance predictive accuracy for ischemic stroke subtypes

Combined polygenic scores for ischemic stroke risk factors aid risk assessment of ischemic stroke

Polygenic risk score predicts all-cause death in East Asian patients with prior coronary artery disease

Development, Validation and Comparison of Multivariable Risk Scores for Prediction of Total Stroke and Stroke Types in Chinese Adults: a Prospective Study of 0.5 Million Adults

Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke

Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population

Association Between Genetic Predisposition and Disease Burden of Stroke in China: a Genetic Epidemiological Study.

Joint Impact of Polygenic Risk Score and Lifestyles on Early- and Late-Onset Cardiovascular Diseases

Abstract WMP105: Association of Comorbidities, Stroke Etiology, and Polygenic Risk Score in Japanese Ischemic Stroke Patients

Association of CASZ1 Genetic Variants with Stroke Risk in the Chinese Population

Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians

Large‐Scale Targeted Sequencing Study of Ischemic Stroke in the Han Chinese Population